Free Trial

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical logo
$440.94 -8.75 (-1.95%)
Closing price 10/7/2025 04:00 PM Eastern
Extended Trading
$441.46 +0.51 (+0.12%)
As of 04:10 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Intuitive Surgical - Analysts' Recommendations and Stock Price Forecast (2025)

Consensus Rating

Sell
1
Hold
7
Buy
14

Based on 22 Wall Street analysts who have issued ratings for Intuitive Surgical in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 1 has given a sell rating, 7 have given a hold rating, and 14 have given a buy rating for ISRG.

Consensus Price Target

$589.43
33.68% Upside
According to the 22 analysts' twelve-month price targets for Intuitive Surgical, the average price target is $589.43. The highest price target for ISRG is $700.00, while the lowest price target for ISRG is $440.00. The average price target represents a forecasted upside of 33.68% from the current price of $440.94.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for ISRG and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Intuitive Surgical and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ISRG Analyst Ratings Over Time

TypeCurrent Forecast
10/8/24 to 10/8/25
1 Month Ago
9/8/24 to 9/8/25
3 Months Ago
7/10/24 to 7/10/25
1 Year Ago
10/9/23 to 10/8/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
14 Buy rating(s)
13 Buy rating(s)
15 Buy rating(s)
15 Buy rating(s)
Hold
7 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
5 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$589.43$595.95$592.59$454.35
Forecasted Upside33.68% Upside26.80% Upside12.65% Upside-5.50% Downside
Consensus RatingModerate BuyModerate BuyModerate BuyModerate Buy

ISRG Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

ISRG Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Intuitive Surgical Stock vs. The Competition

TypeIntuitive SurgicalMedical CompaniesS&P 500
Consensus Rating Score
2.59
2.33
2.51
Consensus RatingModerate BuyHoldModerate Buy
Predicted Upside33.68% Upside1,337.26% Upside170.15% Upside
News Sentiment Rating
Positive News

See Recent ISRG News
Positive News
Positive News
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside
Details
10/7/2025Evercore ISI
3 of 5 stars
Vijay Kumar
Vijay Kumar
Not Rated
Lower TargetIn-Line$535.00 ➝ $450.00+1.90%
10/1/2025The Goldman Sachs Group
3 of 5 stars
 Lower TargetBuy$621.00 ➝ $567.00+26.78%
10/1/2025BTIG Research
2 of 5 stars
Ryan Zimmerman
Ryan Zimmerman
5 of 5 stars
Reiterated RatingBuy$571.00+27.67%
9/27/2025Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingHold (C+)
8/22/2025Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingSell
8/20/2025Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 DowngradeStrong-BuyHold
8/19/2025Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOutperform$615.00+26.99%
7/23/2025UBS Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetNeutral$547.00 ➝ $585.00+16.55%
7/23/2025Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight$575.00 ➝ $595.00+19.91%
7/23/2025Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetBuy$590.00 ➝ $600.00+20.81%
7/23/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$559.00 ➝ $599.00+18.92%
7/23/2025Erste Group Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuyHold
5/22/2025Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$590.00 ➝ $650.00+19.27%
4/24/2025Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOverweight$684.00 ➝ $635.00+24.97%
4/23/2025Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower TargetOutperform$600.00 ➝ $575.00+20.11%
1/27/2025CICC Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageNeutral$550.00-4.17%
1/27/2025Leerink Partners
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost Target$490.00 ➝ $548.00-4.43%
1/27/2025Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost Target$475.00 ➝ $575.00+0.30%
1/27/2025Bernstein Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetOverweight$655.00 ➝ $700.00+22.16%
1/24/2025Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOutperform$560.00 ➝ $688.00+17.20%
1/24/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost TargetOverweight$575.00 ➝ $675.00+10.90%
12/5/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Boost TargetBuy$525.00 ➝ $610.00+11.22%
12/2/2024Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 UpgradeEqual WeightOverweight$522.00 ➝ $650.00+19.93%
10/18/2024Oppenheimer
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingMarket Perform
10/17/2024Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Target$440.00 ➝ $500.00+5.30%
8/2/2024Redburn Atlantic
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeNeutralBuy$380.00 ➝ $510.00+13.10%
11/17/2023HSBC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Initiated CoverageBuy$318.00+4.62%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 04:10 AM ET.


Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, October 7, 2025. Please send any questions or comments about these Intuitive Surgical pros and cons to contact@marketbeat.com.

Intuitive Surgical
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Intuitive Surgical, Inc.:

  • The stock has shown strong performance with a market capitalization of approximately $162 billion, indicating a robust position in the medical equipment sector.
  • Recent quarterly earnings reported a significant earnings per share (EPS) of $2.19, surpassing analysts' expectations, which reflects strong operational performance.
  • Intuitive Surgical, Inc. has experienced a year-over-year revenue growth of over 21%, showcasing its ability to expand and capture market share effectively.
  • The current stock price is around $452, which may present a buying opportunity for investors looking to enter at a lower price point compared to its 12-month high.
  • With a return on equity of 14.56%, the company demonstrates efficient use of shareholders' equity to generate profits, which is a positive indicator for potential investors.

Intuitive Surgical
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Intuitive Surgical, Inc. for these reasons:

  • The stock has a high price-to-earnings (P/E) ratio of around 63, which may suggest that it is overvalued compared to its earnings, potentially leading to a price correction.
  • With a beta of 1.61, the stock is more volatile than the market, indicating that it may experience larger price swings, which could be risky for conservative investors.
  • Despite recent growth, the company faces increasing competition in the medical equipment industry, which could impact its market share and profitability in the future.
  • The price-to-earnings-growth (P/E/G) ratio of 4.64 suggests that the stock may be expensive relative to its growth rate, which could deter value-focused investors.
  • Institutional investors hold a significant portion of the stock (over 83%), which may lead to increased volatility if large shareholders decide to sell their positions.

ISRG Forecast - Frequently Asked Questions

According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Intuitive Surgical is $589.43, with a high forecast of $700.00 and a low forecast of $440.00.

22 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last year. There is currently 1 sell rating, 7 hold ratings and 14 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ISRG shares.

According to analysts, Intuitive Surgical's stock has a predicted upside of 33.68% based on their 12-month stock forecasts.

Over the previous 90 days, Intuitive Surgical's stock had 1 downgrade by analysts.

Analysts like Intuitive Surgical more than other "medical" companies. The consensus rating for Intuitive Surgical is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how ISRG compares to other companies.


This page (NASDAQ:ISRG) was last updated on 10/8/2025 by MarketBeat.com Staff
From Our Partners